Status:
UNKNOWN
Anti-Tissue Transglutaminase IgA Antibodies
Lead Sponsor:
Assiut University
Conditions:
Celiac Disease in Children
Eligibility:
All Genders
1-18 years
Brief Summary
Celiac disease is the most common genetically related food intolerance, worldwide. It is an immune mediated intolerance to gluten (from wheat, barley, or rye) in genetically susceptible individuals .T...
Detailed Description
Within this definition, patients can further be defined as having silent, potential, or latent celiac disease. The term silent celiac disease refers to patients fulfilling the definition above, but pr...
Eligibility Criteria
Inclusion
- • patients with symptoms suggestive of celiac disease
Exclusion
- •chronic active gastrointestinal disease, i.e., irritable bowel syndrome inflammatory bowel disease .
Key Trial Info
Start Date :
October 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2021
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04019223
Start Date
October 1 2019
End Date
March 1 2021
Last Update
July 15 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.